Pacira BioSciences, Inc. (NASDAQ:PCRX) Receives $27.22 Average Price Target from Analysts
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) has earned a consensus recommendation of “Hold” from the nine research firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and four have issued a buy recommendation on the […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) has earned a consensus recommendation of “Hold” from the nine research firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and four have issued a buy recommendation on the […]